rs776242172

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_000719.7(CACNA1C):​c.1381C>A​(p.Pro461Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000897 in 1,450,002 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P461A) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000090 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

3
10
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 7.46

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAdExome4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.1471C>A p.Pro491Thr missense_variant Exon 9 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.1471C>A p.Pro491Thr missense_variant Exon 9 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.1471C>A p.Pro491Thr missense_variant Exon 9 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.1471C>A p.Pro491Thr missense_variant Exon 9 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.1471C>A p.Pro491Thr missense_variant Exon 9 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.1471C>A p.Pro491Thr missense_variant Exon 9 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.1372C>A p.Pro458Thr missense_variant Exon 9 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.1381C>A p.Pro461Thr missense_variant Exon 9 of 46 ENSP00000507309.1
CACNA1CENST00000480911.6 linkn.1113+19589C>A intron_variant Intron 7 of 26 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000439
AC:
1
AN:
227536
AF XY:
0.00000815
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000980
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000897
AC:
13
AN:
1450002
Hom.:
0
Cov.:
31
AF XY:
0.00000694
AC XY:
5
AN XY:
719986
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33302
American (AMR)
AF:
0.00
AC:
0
AN:
43106
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25832
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39300
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83764
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52644
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5742
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1106306
Other (OTH)
AF:
0.0000167
AC:
1
AN:
60006
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000826
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Feb 12, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Long QT syndrome Uncertain:1
Oct 05, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline with threonine at codon 461 of the CACNA1C protein (p.Pro461Thr). The proline residue is moderately conserved and there is a small physicochemical difference between proline and threonine. This variant is present in population databases (rs776242172, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 456945). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
CardioboostArm
Uncertain
0.16
BayesDel_addAF
Pathogenic
0.31
D
BayesDel_noAF
Pathogenic
0.21
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.069
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
1.0
D
M_CAP
Uncertain
0.27
D
MetaRNN
Uncertain
0.64
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.70
D
MutationAssessor
Benign
1.4
.;L;.;L;L;L;L;L;L;L;L;L;L;L;L;L;.;L;L;L;.;.;.
PhyloP100
7.5
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-2.7
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Uncertain
0.61
Sift
Benign
0.24
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.17
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
1.0, 0.028, 0.85, 0.61, 0.11
.;D;.;B;P;P;D;D;D;B;D;D;D;D;D;D;.;D;D;.;.;.;D
Vest4
0.73
MutPred
0.27
Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);Gain of phosphorylation at P461 (P = 0.0041);
MVP
0.89
MPC
2.1
ClinPred
0.95
D
GERP RS
4.4
gMVP
0.93
Mutation Taster
=48/52
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs776242172; hg19: chr12-2622141; API